Get insights on two critical topics:
- Challenges and imperatives to obtain approval of your Digital Therapeutic
Discuss the challenges and imperatives to obtain approval of digital therapeutics in both Europe and the U.S., the continued advances and changes in digital medicine and telemedicine worldwide, and the roadmap to success.
- Explore the reimbursement opportunities in Europe and the U.S.
Understand the key players and influencers in both markets and how to navigate the regulatory, access and reimbursement landscape.
- Ed Corbett, Head of EMEA, EVERSANA CONSULTING
- Jessica Shull, European Lead at Digital Therapeutics Alliance
- Martin Culjat, Ph.D., SVP, Regulatory Innovation & Digital Medicine, EVERSANA
Request your 1-hour FREE Digital Strategy Assessment ここ
Watch the full workshop below!
EVERSANA employs a team of over 6000 professionals across 40+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…